Zink S, Rösen P, Sackmann B, Lemoine H
Diabetes Research Institute, Düsseldorf, Germany.
Biochim Biophys Acta. 1993 Sep 13;1178(3):286-98. doi: 10.1016/0167-4889(93)90206-5.
The barrier function of cultured, macrovascular endothelial cells derived from bovine aorta was analyzed using confluent monolayers of cells and measuring the exchange of fluorescein dextrans of different molecular masses. The effects of beta-adrenoceptor agonists with different selectivity for beta 1- and beta 2-adrenoceptors (AR) were investigated. Formoterol, a novel high-affinity agonist for beta 2-AR recently introduced in the treatment of bronchial asthma, showed a significant reduction of cell permeability with subnanomolar concentrations, whereas the catecholamines (-)-isoproterenol and (-)-norepinephrine only showed significant effects with micromolar concentrations. In order to elucidate if this difference in potential to regulate cell permeability is related to appropriate changes in the selectivity and affinity of the agonists for beta 2 AR, we investigated the beta AR-coupled adenylate cyclase (AC) in membranes from endothelial cells and compared AC stimulation with the binding of agonists to the receptors using 125I-iodopindolol as radioligand. beta-Adrenoceptors revealed to be closely coupled to AC as assessed by a similar magnitude of effects by receptor agonists in comparison to GTP analogues and direct stimulants of AC activity. AC activity was increased by formoterol in parallel to its receptor occupancy of beta 2AR with nanomolar concentrations which were 50-fold higher than those used for the regulation of cell permeability indicating the existence of spare receptors. In contrast to formoterol, the catecholamines (-)-isoproterenol and (-)-norepinephrine stimulated AC activity through both beta 1AR and beta 2AR. From the overproportional high contribution of beta 1AR to AC stimulation (42%) in comparison to its low fraction (13%) in receptor binding we calculated that beta 1AR is 3-4-fold more effectively coupled to AC than beta 2 AR.
利用汇合的单层细胞并测量不同分子量的荧光素葡聚糖的交换,分析了源自牛主动脉的培养大血管内皮细胞的屏障功能。研究了对β1和β2肾上腺素能受体(AR)具有不同选择性的β肾上腺素能受体激动剂的作用。福莫特罗是一种最近用于治疗支气管哮喘的新型高亲和力β2-AR激动剂,在亚纳摩尔浓度下可显著降低细胞通透性,而儿茶酚胺(-)-异丙肾上腺素和(-)-去甲肾上腺素仅在微摩尔浓度下显示出显著作用。为了阐明调节细胞通透性的潜力差异是否与激动剂对β2 AR的选择性和亲和力的适当变化有关,我们研究了内皮细胞膜中β AR偶联的腺苷酸环化酶(AC),并使用[125I](-)-碘吲哚洛尔作为放射性配体,将AC刺激与激动剂与受体的结合进行了比较。与GTP类似物和AC活性的直接刺激剂相比,受体激动剂的作用程度相似,表明β肾上腺素能受体与AC紧密偶联。福莫特罗在纳摩尔浓度下可增加AC活性,与其对β2AR的受体占有率平行,该浓度比用于调节细胞通透性的浓度高50倍,表明存在备用受体。与福莫特罗相反,儿茶酚胺(-)-异丙肾上腺素和(-)-去甲肾上腺素通过β1AR和β2AR刺激AC活性。与β1AR在受体结合中的低比例(13%)相比,其对AC刺激的过高贡献(42%)表明,β1AR与AC偶联的效率比β2 AR高3-4倍。